Compound Detail
CHEMBL1002
LEVOSALBUTAMOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1002 |
| Name | LEVOSALBUTAMOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | NDAUXUAQIAJITI-LBPRGKRZSA-N |
| Therapeutic | ✓ Yes |
1
Targets
12
Activities
2
Assay Types
0
PK Parameters
7
Publications
5
Known Names
2
Indications
Molecular Properties
239.3
MW (Da)
1.31
ALogP
4
HBA
4
HBD
72.7
PSA (Ų)
0.64
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1999 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Asthma Pulmonary Disease, Chronic Obstructive
Activity Summary
EC50 6 meas. best 6.84
Ki 6 meas. best 5.42
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL210 | EC50 | 6.84 | 6.58 | 144.5 | 6 |
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 5.42 | 5.3333 | 3801.9 | 6 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22182578 | 10.1016/j.bmc.2011.11.054 | Beta-2 adrenergic receptor | 19 |
| 22182578 | 10.1016/j.bmc.2011.11.054 | Unchecked | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 3005570 | 10.1021/jm00152a017 | Erythrocyte beta receptor | 1 |
| 10841799 | 10.1021/jm990968+ | Mus musculus | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 1 |
Data from ChEMBL 36 via Core Engine